Supreme Court shields Roundup from failure-to-warn claims
Analysis based on 133 articles · First reported Jun 25, 2026 · Last updated Jul 06, 2026
Bayer's stock surged nearly 18% as the ruling removes a major legal overhang, potentially saving billions in future liabilities. The decision also benefits the broader pesticide industry by limiting state-level tort claims, but may increase regulatory and political scrutiny from MAHA advocates.
The U.S. Supreme Court ruled 7-2 in Bayer — Monsanto Co. v. Durnell that federal pesticide law (FIFRA) preempts state-law failure-to-warn claims against Bayer's Roundup weedkiller, because the EPA has not required a cancer warning. The decision overturns a $1.25 million United States — Missouri jury verdict for plaintiff John Durnell, who developed non-Hodgkin lymphoma after decades of Roundup use. The ruling is expected to block thousands of similar lawsuits, significantly reducing Bayer's litigation exposure. Bayer had already set aside $16 billion for settlements and proposed a $7.25 billion class-action settlement. The Trump administration supported Bayer, causing tension with the Make America Healthy Again movement. Critics, including environmental groups and some lawmakers, denounced the decision. Bayer shares rose nearly 18% after the ruling. Separately, New Zealand's reliance on Bayer — Monsanto-influenced reviews for glyphosate approval has come under scrutiny, with one review retracted and two under investigation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard